Evaluation of growth and of endocrine systems in testosterone-corticosteroid-treated patients with aplastic anemia.
D000311:Adrenal Glands / Q000187:drug effects*; D000365:Age Determination by Skeleton; D000741:Anemia, Aplastic / Q000188:drug therapy*; D001827:Body Height; D002648:Child; D002675:Child, Preschool; D005474:Fluoxymesterone / Q000627:therapeutic use*; D006128:Growth / Q000187:drug effects*; D006801:Humans; D008297:Male; D008777:Methyltestosterone / Q000627:therapeutic use*; D010902:Pituitary Gland / Q000187:drug effects*; D011241:Prednisone / Q000627:therapeutic use*; D013737:Testis / Q000187:drug effects*; D013739:Testosterone / Q000627:therapeutic use*; D013961:Thyroid Gland / Q000187:drug effects*; D014221:Triamcinolone / Q000627:therapeutic use*
D014221:Triamcinolone; D013739:Testosterone; D005474:Fluoxymesterone; D008777:Methyltestosterone; D011241:Prednisone